cytisine has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borisevich, SS; Khvostov, MV; Kuranov, SO; Luzina, OA; Salakhutdinov, NF; Tsypysheva, IP; Vakhitova, YV; Zainullina, LF | 1 |
| Banach, M; Bielecka-Dąbrowa, A; Dąbrowa, M; Gąsiorek, P; Paduszyńska, A; Rysz, J | 1 |
| An, W; Cui, Q; Jia, J; Jin, L; Li, Z; Tan, H; Tu, J | 1 |
3 other study(ies) available for cytisine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Synthesis and evaluation of camphor and cytisine-based cyanopyrrolidines as DPP-IV inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Alkaloids; Animals; Azocines; Binding Sites; Camphor; Catalytic Domain; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Male; Mice; Molecular Docking Simulation; Pyrrolidines; Quinolizines; Structure-Activity Relationship | 2018 |
Cytisine - From the Past to the Future.
Topics: Alkaloids; Animals; Antidepressive Agents; Azocines; Diabetes Mellitus, Type 2; Humans; Neuroprotective Agents; Nicotinic Agonists; Quinolizines; Receptors, Nicotinic | 2018 |
Drug-repurposing identified the combination of Trolox C and Cytisine for the treatment of type 2 diabetes.
Topics: Alkaloids; Animals; Azocines; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Male; Mice; Mice, Inbred ICR; Quinolizines | 2014 |